Silence Therapeutics closes upsized $201.3 million ADS follow-on offering at $13.5 each

Silence Therapeutics completed an upsized follow-on offering of 14,907,407 ADSs at $13.5 each, raising approximately $201.3 million in gross proceeds. The deal included the full exercise of underwriters' options for an additional 1,944,444 ADSs. Each ADS represents three ordinary shares.

Silence Therapeutics closed an upsized underwritten public offering of 14,907,407 ADSs at $ 13.5 per ADS. * Gross proceeds totaled about $ 201.3 million before underwriting discounts, commissions, and offering expenses. * Deal size included the full exercise of underwriters’ option for an additional 1,944,444 ADSs. * Each ADS represents three ordinary shares of £0.05 each. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Silence Therapeutics plc published the original content used to generate this news brief via Business Wire (Ref. ID: 202608141655BIZWIRE_USPR_____20260814_BW817164) on August 14, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)